Xtant Medical Holdings, Inc. (XTNT) stock
XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3080% below fair value
$0.21−0.00 (-2.19%)
Close on Nov 17, 2026Market cap $28.79MP/E –Yield –
Xtant Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Xtant Medical's operating cash flow for the twelve months ending Jun 30, 2026 was $570.00K, down 62.0% year over year. For fiscal 2025 it was $12.55M. The highest annual figure on record is $12.55M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.55M | – |
| FY2024 | Dec 31, 2024 | -$11.90M | – |
| FY2023 | Dec 31, 2023 | -$9.52M | – |
| FY2022 | Dec 31, 2022 | -$5.34M | -1316.6% |
| FY2021 | Dec 31, 2021 | $439.00K | – |
| FY2020 | Dec 31, 2020 | -$731.00K | – |
| FY2019 | Dec 31, 2019 | -$413.00K | -134.1% |
| FY2018 | Dec 31, 2018 | $1.21M | – |
| FY2017 | Dec 31, 2017 | -$543.00K | – |
| FY2016 | Dec 31, 2016 | -$14.41M | – |
| FY2015 | Dec 31, 2015 | -$9.10M | – |
| FY2014 | Dec 31, 2014 | -$7.32M | – |
| FY2013 | Dec 31, 2013 | -$4.89M | – |
| FY2012 | Dec 31, 2012 | -$10.79M | – |
| FY2011 | Dec 31, 2011 | -$7.36M | – |
| FY2010 | Dec 31, 2010 | -$8.37M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.31M | -672.7% |
| Q1 FY2026 | Mar 31, 2026 | -$2.11M | -265.4% |
| Q4 FY2025 | Dec 31, 2025 | $5.38M | +709.0% |
| Q3 FY2025 | Sep 30, 2025 | $4.61M | – |
| Q2 FY2025 | Jun 30, 2025 | $1.28M | – |
| Q1 FY2025 | Mar 31, 2025 | $1.28M | – |
| Q4 FY2024 | Dec 31, 2024 | $665.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.72M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.09M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.76M | – |
| Q4 FY2023 | Dec 31, 2023 | -$915.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.83M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.52M | -16906.7% |
| Q1 FY2023 | Mar 31, 2023 | -$2.25M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.29M | -640.9% |
| Q3 FY2022 | Sep 30, 2022 | -$2.06M | – |
| Q2 FY2022 | Jun 30, 2022 | $15.00K | -99.3% |
| Q1 FY2022 | Mar 31, 2022 | -$1.00M | – |
| Q4 FY2021 | Dec 31, 2021 | $423.00K | -53.8% |
| Q3 FY2021 | Sep 30, 2021 | -$926.00K | – |
| Q2 FY2021 | Jun 30, 2021 | $2.25M | +955.9% |
| Q1 FY2021 | Mar 31, 2021 | -$1.31M | – |
| Q4 FY2020 | Dec 31, 2020 | $916.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$71.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $213.00K | -54.1% |
| Q1 FY2020 | Mar 31, 2020 | -$1.79M | -465.1% |
| Q4 FY2019 | Dec 31, 2019 | -$71.00K | -103.6% |
| Q3 FY2019 | Sep 30, 2019 | -$1.30M | – |
| Q2 FY2019 | Jun 30, 2019 | $464.00K | +329.6% |
| Q1 FY2019 | Mar 31, 2019 | $490.00K | +107.6% |
| Q4 FY2018 | Dec 31, 2018 | $1.99M | +208.2% |
| Q3 FY2018 | Sep 30, 2018 | -$1.12M | – |
| Q2 FY2018 | Jun 30, 2018 | $108.00K | – |
| Q1 FY2018 | Mar 31, 2018 | $236.00K | -46.0% |
| Q4 FY2017 | Dec 31, 2017 | $646.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$433.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.19M | – |
| Q1 FY2017 | Mar 31, 2017 | $437.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.21M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.44M | – |
See a number that looks wrong?